








































Fluid loading therapy to prevent spinal hypotension
in women undergoing elective caesarean section
Network meta-analysis, trial sequential analysis and
meta-regression
Koen Rijs, Frederic J. Mercier, D. Nuala Lucas, Rolf Rossaint, Markus Klimek and Michael Heesen
BACKGROUND Fluid loading is one of the recognised
measures to prevent hypotension due to spinal anaesthesia
in women scheduled for a caesarean section.
OBJECTIVE We aimed to evaluate the current evidence on
fluid loading in the prevention of spinal anaesthesia-induced
hypotension.
DESIGN Systematic review and network meta-analysis with
trial sequential analysis and meta-regression.
DATA SOURCES Medline, Epub, Embase.com (Embase
and Medline), Cochrane Central, Web of Science and Goo-
gle Scholar were used.
ELIGIBILITY CRITERIA Only randomised controlled trials
were used. Patients included women undergoing elective
caesarean section who received either crystalloid or colloid
fluid therapy as a preload or coload. The comparator was a
combination of either a different fluid or time of infusion.
RESULTS A total of 49 studies (4317 patients) were
included. Network meta-analysis concluded that colloid
coload and preload offered the highest chance of success
(97 and 67%, respectively). Conventional meta-analysis
showed that crystalloid preload is associated with a signifi-
cantly higher incidence of maternal hypotension than colloid
preload: risk ratio 1.48 (95% CI 1.29 to 1.69, P<0.0001,
I2¼60%). However, this result was not supported by Trial
Sequential Analysis. There was a significant dose–response
effect for crystalloid volume preload (regression
coefficient¼0.073), which was not present in the analysis
of only double-blind studies. There was no dose–response
effect for the other fluid regimes.
CONCLUSION Unlike previous meta-analysies, we found a
lack of data obviating an evidence-based recommendation.
In most studies, vasopressors were not given prophylacti-
cally as is recommended. Studies on the best fluid regimen in
combination with prophylactic vasopressors are needed.
Due to official european usage restrictions on the most
studied colloid (HES), we recommend crystalloid coload
as the most appropriate fluid regimen.
TRIAL REGISTRATION CRD42018099347.
Published online 23 October 2020
Introduction
Hypotension following spinal anaesthesia for caesarean
section can occur in up to 80% of women without pro-
phylactic measures.1 For many years, this was believed to
arise primarily as a result of venous vasodilation. How-
ever, studies that have utilised cardiac output monitoring
have demonstrated that arterial vasodilation is more
likely to be responsible for the decrease in blood pressure
following spinal anaesthesia, at least initially.2 The focus
of attention for prophylaxis and management has there-
fore shifted from fluid-loading strategies to the extensive
investigation of the role of vasopressors. Currently, the
alpha-agonist phenylephrine, which directly counteracts
the sympatholysis-induced decrease in arterial resistance
and is associated with a lower incidence of foetal acidosis,
has become the preferred agent.3,4 A phenylephrine
infusion commencing at the time of the spinal injection
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is currently recommended as the most effective approach
to prevent hypotension,5,6 although phenylephrine
boluses given prophylactically or noradrenaline infusion
may be at least as effective.7–9
However, fluid loading strategies remain another part of
an antihypotensive strategy, as they can counteract the
relative hypovolaemia due to venodilation and, by
increasing the venous return, help to maintain haemo-
dynamic stability.1 Despite the effectiveness of phenyl-
ephrine, a significantly higher frequency of hypotension
has been observed when no fluid is given.10 In addition,
the CAESAR study demonstrated that a mixed hydro-
xyethyl starch–Ringer’s lactate based preload infusion
reduced maternal hypotension compared with a pure
Ringer’s lactate based preload when combined with
intravenous (i.v.) phenylephrine boluses. In addition,
the decrease in the incidence of severe and/or symptom-
atic hypotension is even more pronounced.11 A survey
showed that many obstetric anaesthetists still favour fluid
therapy in their clinical practice.12
Recently, a meta-analysis was published focusing on the
use of vasopressors in the prevention of hypotension after
spinal anaesthesia for caesarean delivery.13 This found
that either norepinephrine or metaraminol is less likely
than phenylephrine to affect foetal acid-base status
adversely. Another meta-analysis addressing methods
to prevent hypotension after spinal anaesthesia for cae-
sarean section was also recently published14: the main
focus was on vasopressor use, but also included fluid
therapy. Metaraminol was found to be the most effective
vasopressor, and colloid, given as a preload, was the most
effective fluid for preventing maternal hypotension.
However, it is unclear whether this meta-analysis is
sufficiently powered to make firm conclusions. Previ-
ously, it has been shown that the conclusions of meta-
analyses that do not incorporate trial sequential analysis
(TSA) are often premature due to a lack of sufficient
data.15,16 The use of TSA can calculate the power of a
meta-analysis and thereby provide more definite and
reliable conclusions.17
Traditional meta-analysis only enables direct pairwise
comparison of two interventions. Although most studies
have two treatment arms for fluid therapy, there are
variations in the combinations of time of administration
and type of fluid used. We therefore chose to carry out a
network meta-analysis, which allows conclusions from
indirect comparisons: if regimen A is better than B and
if C is better than B, then network meta-analysis allows
for conclusions on the relationship between C and A,
although no direct comparisons have been performed.
Consequently, this statistical method is more appropriate
than conventional meta-analysis. for suggesting the most
promising treatment regimen. The aim of this article is to
define the best fluid strategy to prevent spinal anaesthe-
sia-induced hypotension in elective caesarean section.
Materials and methods
Protocol and registration
Our study was registered with PROSPERO (https://www.
crd.york.ac.uk, registration number CRD42018099347)
and was conducted in agreement with the PRISMA state-
ment.18
Search strategy
We performed an electronic search on 22 October 2019,
searching the databases Medline, Epub, Embase.com
(Embase and Medline), Cochrane Central, Web of Sci-
ence and Google Scholar, with details of the search
strategy given in the appendix (S2. Details of literature
search, http://links.lww.com/EJA/A404). There was no
language restriction.
Eligibility criteria and study selection
We used the items of the PICOS acronym to define
inclusion criteria:
Patients: Adult (as defined by the authors of the studies)
women undergoing elective caesarean section.
Intervention: Two types of fluid were studied, crystal-
loid and colloid, given at one of two possible time-
points: A, as a preload before spinal anaesthesia and B,
as a coload on injection of the spinal medication.
Comparator: Each of the above fluid/time combinations
was compared with a combination that had either a
different fluid (number) or time (letter) ofadministration.
Outcomes: Primary outcome: incidence of maternal
hypotension, as defined by the individual authors.
Secondary outcomes: umbilical artery pH, ephedrine
use, phenylephrine use, nausea and vomiting.
Study type: Only randomised controlled trials
were included.
Data collection and data extraction
Two authors (KR, MH) independently extracted data
from the original papers and entered them into the
RevMan file. These authors also screened the retrieved
references and performed the risk of bias assessment,
with discrepancies being resolved by discussion. In case
this was not possible, our protocol stipulated involvement
of a third author (MK). Risk ratios of dichotomous vari-
ables or mean differences of continuous variables and
95% confidence intervals were computed.
Assessment of the methodological quality
The risks of selection, performance, detection and attri-
tion bias were assessed with the Cochrane tool19 and
entered into the RevMan file. Only double-blind studies
were considered as ‘low risk of bias studies’. For our
primary outcome, we assessed the quality of evidence
according to The Grading of Recommendations Assess-
ment, Development and Evaluation (GRADE) working
group approach.20 Evidence may be downgraded due to
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We used the random effects model because heterogene-
ity was expected. An aggregate effect estimate was only
calculated when there were at least three studies with a
combined total of 100 patients (minimum) per treatment
group. To estimate heterogeneity in our analyses, the I2
statistic was used.21 A P value of less than 0.05 was used as
an indicator of statistical significance. For further clarifi-
cation of our findings, a sensitivity analysis was performed
based on the blinding status of studies: only double-blind
studies were analysed. We also intended to carry out a
similar sensitivity analysis on vasopressor use; prophylac-
tically or therapeutically given.
Network meta-analysis
To compare the different treatment regimens, we used
network meta-analysis (NMA), a statistical approach that
combines direct and indirect evidence into single treat-
ment effects.22,23 For the calculations, we used the fre-
quentist method, based on the graph-theoretical method
by Rücker et al.24 Treatment effects were expressed as
risk ratios or mean difference with corresponding 95%
confidence intervals (95% CIs). The I2 statistic was used
to assess heterogeneity in the network analysis. Potential
inconsistency was explored by looking at differences
between estimates from direct and indirect compari-
sons.25 The results of the NMA were presented in a
league table. All pairwise comparisons are given in a
square matrix. The treatments were ranked by P-scores.
P-scores are based on the point estimate and standard
errors of the network estimates. A P-score is an averaged
measure of the extent of certainty that a treatment is
better than others.26 The league table is sorted by the P-
scores. A sensitivity analysis was performed including
only double-blind studies.
Meta-regression
To look for dose–response relationships of volume, we
performed a meta-regression. A random effects model
was used. Proportions of events were log transformed. All
analyses were presented in bubble plots. When signifi-
cant differences were found, we performed a sensitivity
analysis on the double-blind studies.
Trial sequential analysis
This analysis was performed only for the ‘low risk of bias’
studies for our primary outcome namely, the incidence of
maternal hypotension. The methodology has been
described earlier.27 In short, cumulative meta-analyses
are at risk of type I errors (false positive results) and type
II errors (false negative results) because of repetitive
testing as data accumulates.17,28,29 Trial sequential analy-
sis (TSA) aims to adjust the statistical threshold to
minimise these errors. Results are presented as a graph
with lines representing the cumulative Z-curve (the Z test
curve is updated after each study is added), a conventional
line of significance (Z score¼ 1.96 for a P value threshold or
alpha of 5%), the required information size (RIS), the
futility boundaries and a trial sequential monitoring
boundary as based on the O’Brien-Fleming alpha-spend-
ing function. RIS is calculated allowing for a type I error of
5% and a type II error of 20% and heterogeneity was set to
25%. TSA figures will only be presented when trial
sequential monitoring or futility boundaries were crossed.
Publication bias
A comparison-adjusted funnel plot was made to visually
inspect the possibility of publication bias. We also per-
formed the Egger test.30 We did the analysis for all
studies and for the double-blind studies only.
Statistical programmes
Conventional meta-analysis, NMA and meta-regression
were performed using RStudio (version 1.0.153; Inte-
grated Development for R. RStudio, Inc., Boston, Mas-
sachusetts, USA) with package ‘netmeta’ (version 0.9–8),
and ‘meta’ (version 4.9–7). Trial sequential analysis
software (version 0.9; Copenhagen Trial Unit, Copenha-
gen, Denmark) was used to perform this analysis.
Results
Study selection and study characteristics
With our systematic literature search, we found 49 trials
considered as eligible for our analysis (Fig. 1).11,31–78
These included 4317 patients in total. Details of the
studies are given in Table 1. Only three of the 49 studies
(6%) used a prophylactic vasopressor. All 49 studies
included therapeutic vasopressor use in their study pro-
tocol. Ephedrine was most often used as the vasopressor
(74%), followed by phenylephrine (14%), a combination
of ephedrine and phenylephrine (8%), and less often used
were mephentermine (2%) and metamarinol (2%).
Risk of bias within studies
The risk of bias summary is presented in Fig. 2 and the
GRADE quality of evidence can be found in Table 2. A
total of 19 out of 49 studies (39%) were double-blind.
Primary outcome was incidence of hypotension
Conventional meta-analysis
Figure 3 shows the conventional meta-analysis for the
incidence of hypotension. Significant results were found
for the comparison of crystalloid coload with colloid coload,
with a risk ratio of 1.55 (95% CI 1.25 to 1.92, P< 0.0001,
I2¼ 0%) (Fig. 3a). Crystalloid preload compared with
colloid preload gave a risk ratio for incidence of hypoten-
sion of 1.48 (95% CI 1.29 to 1.69, P< 0.0001, I2¼ 60%
(Fig. 3b). Risk ratio for crystalloid preload compared with
crystalloid coload was 1.31 (95% CI 1.04 to 1.65, P¼ 0.02,
I2¼ 69%) (Fig. 3c). There were no significant differences
1128 Rijs et al.
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for the comparison colloid preload vs. colloid coload; risk
ratio of 1.01 (95% CI 0.84 to 1.20, P¼ 0.92, I2¼ 12%)
(Fig. 3d). The other comparisons had less than three
studies; hence, no effect estimate was calculated.
Trial sequential analysis
For all comparisons, the cumulative Z-curve did not cross
the trial sequential monitoring or futility boundary,
indicating that all these meta-analyses were insufficiently
powered to answer the clinical question.
Network meta-analysis
In Figure 4a, we present the network geometry for the
primary outcome. Figure 4b shows a forest plot of the
network meta-analysis for the primary outcome. In
Figure 4c, we present a league table sorted by rank. This
shows that colloid coload had a 97% chance of being the
Fluid loading for prevention of spinal hypotension 1129
Fig. 1. Flow chart of the literature search
Records identified through database
searching: n = 3178 
Abstracts screened: n = 1398 
Full-text articles assessed for eligibility: 
n = 80 Records excluded: n = 31 
Number of studies included in 
qualitative synthesis: n = 49 
Records after duplicates removed: n = 1398 
Records excluded: n = 1318 
Number of studies included in 
quantitative synthesis (meta-analysis): 
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best among all four treatments with the other treatments
much lower: colloid preload (67%), crystalloid coload
(36%) and crystalloid preload (0%). Colloid coload had
a significantly lower incidence of hypotension when
compared with crystalloid coload and crystalloid preload:
risk ratio 0.76 (95% CI 0.61 to 0.95) and RR 0.59 (95% CI
0.47 to 0.73), respectively. There was no significant
difference between colloid coload and colloid preload:
risk ratio 0.87 (95% CI 0.71 to 1.07). Colloid preload
lowers the incidence of hypotension significantly com-
pared with crystalloid preload: risk ratio 0.68 (95% CI 0.60
to 0.76). Crystalloid coload lowers the incidence of hypo-
tension significantly compared with crystalloid preload:
risk ratio 0.77 (95% CI 0.65 to 0.92).
The tau2 for the network model was 0.0475 and the I2
statistic was 52.6%. No significant differences were found
in the consistency analysis that compared the direct and
indirect outcomes (P¼ 0.63).
Sensitivity analysis
In Figure S4a (supplementary material, http://links.lww.-
com/EJA/A403), we present the network graph. Conven-
tional meta-analysis of the low-bias studies showed a
nonsignificant difference between comparison colloid
preload and colloid coload, RR 0.83 (95% CI 0.68 to
1.03, P¼ 0.09, I2¼ 0%). Significant differences were
found between the comparisons crystalloid coload and
colloid coload, as well as between crystalloid preload and
colloid preload: risk ratio 1.46 (95% CI 1.08 to 1.96,
P¼ 0.01, I2¼ 61%) and risk ratio 1.59 (95% CI 1.28 to
1.97, P< 0.0001, I2¼ 61%), respectively (Figure S3b &
S3c, supplementary material, http://links.lww.com/EJA/
A403). For comparisons crystalloid preload with crystal-
loid coload, colloid coload with crystalloid preload and
colloid preload with crystalloid coload, no forest plot is
shown because less than three studies could be included.
As only a limited number of studies used a prophylactic
vasopressor, we decided to not perform a sensitivity analysis.
Network meta-analysis results of the low-bias-studies can
be found in Figure S4c (supplementary material, http://
links.lww.com/EJA/A403). The ranking showed colloid
preload had the highest chance of being the best (79%)
followed by colloid coload (78%), crystalloid coload (37%)
and crystalloid preload (6%). Colloid preload had a lower
chance of hypotension if compared to crystalloid preload:
risk ratio 0.64 (95% CI, 0.52 to 0.78). Colloid coload had a
lower chance of hypotension if compared to crystalloid
preload: risk ratio 0.64 (95% CI, 0.42 to 0.98). All other
comparisons were not significant.
Publication bias
Comparison-adjusted funnel plots can be found in Fig. 5.
The Egger test was significant if we included all studies
(P< 0.01), suggesting possible publication bias. Sensitiv-
ity analysis with only double-blind studies showed a
nonsignificant Egger test (P¼ 0.14), suggesting no
publication bias.
Meta regression
The meta regression can be found in Figure S15 (sup-
plementary material, http://links.lww.com/EJA/A403).
Fluid loading for prevention of spinal hypotension 1133
Fig. 2. Risk of bias summary
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of panlcipants and personnel (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias)
Selective reporting (reporting bias)
Other bias
Low risk of bias Unclear risk of bias High risk of bias
0% 25% 50% 75% 100%











4317 (49 studies) Moderatea No serious inconsistencyb Moderate indirectnessc No imprecision Not likelyd Low quality
a Not all studies were double-blind, possible selection bias. b No significant differences between direct and indirect comparison. c Due to differences in outcome measures.
d There is a possibility of publication bias, but it was not considered sufficient to downgrade the overall quality of evidence.
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We found a significant dose–response relationship for the
volume of crystalloid preload (regression coefficient¼
0.073 (95% CI, 0.142 to 0.005), Figure S15a,
http://links.lww.com/EJA/A403). Sensitivity analysis with
only the double-blind studies found no such relationship
(regression coefficient¼0.06 (95% CI, 0.175 to
0.055). No significant dose–response was found for
crystalloid coload (Figure S15b, http://links.lww.com/
EJA/A403), colloid preload (Figure S15c, http://links.




Conventional analysis of studies comparing crystalloid
preload with colloid preload found a lower requirement
1134 Rijs et al.
Fig. 3. Conventional meta-analysis of the primary outcome
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Heterogeneity: I2 = 0%, r2 = 0, P = 0.73
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1125Random effects model
Heterogeneity: I2 = 60%, r2 = 0.0631, P < 0.01
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for ephedrine use in the colloid preload group, with a
mean difference of 4.49 mg (95% CI 0.66 to 8.32, P¼ 0.02,
I2¼ 90%) (Figure S5b, http://links.lww.com/EJA/A403).
Similarly, comparing crystalloid preload with crystalloid
coload found a lower requirement for ephedrine use in
the crystalloid coload group, with a mean difference of
7.77 mg (95% CI 1.34 to 14.20, P¼ 0.02, I2¼ 90%) (Figure
S5c, http://links.lww.com/EJA/A403). No significant dif-
ferences were found between colloid preload and colloid
coload (Figure S5a, http://links.lww.com/EJA/A403).
Network results are shown in Figure S10, http://links.lww.
com/EJA/A403. Crystalloid preload required most addi-
tional ephedrine if compared to all other fluid regimes.
Phenylephrine use
There were only sufficient data for the comparison of
colloid preload versus colloid coload, and crystalloid
preload versus colloid preload. No significant differences
were found for conventional and network meta-analysis
(Figures S6 and S11, http://links.lww.com/EJA/A403).
Nausea and/or vomiting
A significant increase in the incidence of nausea was
found in studies that compared crystalloid preload with
crystalloid coload, with a risk ratio of 2.15 (95% CI 1.45 to
3.20, P¼ 0.0002, I2¼ 0) (Figure S7b, http://links.lww.-
com/EJA/A403). Network meta-analysis showed signifi-
cantly less nausea with crystalloid coload compared with
crystalloid preload, and colloid coload compared with
crystalloid preload, with risk ratios of 0.51 (95% CI
0.31 to 0.85) and 0.51 (95% CI 0.26 to 0.99), respectively
(Figure S12, http://links.lww.com/EJA/A403). For vomit-
ing, there were no significant differences found in all
comparisons (Figure S8 and S13, http://links.lww.com/
EJA/A403). There were insufficient data for an analysis of
nausea and vomiting as a combined outcome.
Neontatal outcomes
There were no significant differences in the analyses of
umbilical artery pH (Figure S9 and S14, http://links.lww.-
com/EJA/A403). There were insufficient data for an
analysis of neonatal acidosis.



















































Heterogeneity: I2 = 69%, r2 = 0.0767, P < 0.01
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Discussion
As a major result, we found an effectiveness in descend-
ing order, of colloid coload more than colloid preload, and
crystalloid coload more than crystalloid preload, for the
management of spinal hypotension in women undergoing
elective caesarean section (Fig. 4c). Differing slightly
from this, the sensitivity analysis (including double-blind
studies only) demonstrated that colloid coload and
preload were almost equally effective 78 and 79%,
respectively, whereas crystalloid coload and crystalloid
preload only had a 37 and 6% chance, respectively, of
success (league table: Figure S4c, http://links.lww.com/
EJA/A403).
In direct comparisons, we found a significantly increased
incidence of hypotension when comparing crystalloid
1136 Rijs et al.
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Forest plots for the network meta-analysis of incidence of hypotension. The size of the square
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preload with colloid preload. However, the TSA showed
that there were insufficient data for a definite conclusion
that colloid preload is more effective than crystalloid
preload in preventing hypotension.
Likewise, conventional meta-analysis showed that crys-
talloid coload was more effective in preventing hypoten-
sion than crystalloid preload, but again TSA did not
confirm this finding.
Meta-regression suggested a dose–response effect for
crystalloid preloading only. When nonblind and single-
blind studies were excluded, no dose–response relation-
ship could be found.
With this evaluation, we aimed to present the highest
level of evidence by adding a sensitivity analysis with
only double-blind studies. A total of 39% of our included
articles were double-blind. We consider TSA to be the
most robust statistical method to decide whether there is
sufficient data to make a definite conclusion. In our study,
there was insufficient evidence to draw any definite
conclusion if we combined TSA with only double-blind
studies for the primary outcome, namely the incidence of
maternal hypotension. Despite years of research on this
topic, based on the negative TSA, we still came to same
conclusion as Banerjee et al.79 in 2010 that no significant
differences between any of the fluid loading groups can
be confirmed.
Recently, a network meta-analysis on measures to pre-
vent hypotension was published by Fitzgerald et al.14
This focused mainly on vasopressors, therefore allowing
for only limited comparisons with our study. Another
major difference with our study is that those authors14
defined the administration of 500 ml or less of a crystal-
loid fluid as an inactive control. In our analysis, studies
with this comparator would have been included in com-
parisons with crystalloid administrations, either pre or
coload depending on the time of infusion in the individ-
ual studies. Therefore, the number of studies in the
comparisons differs between Fitzgerald et al., and our
analysis. Fitzgerald et al.14 reported a significantly lower
incidence of hypotension for colloid preload than crystal-
loid preload for low risk of bias studies. However, those
authors used only conventional meta-analysis, while we
added TSA, which did not confirm this finding. We
therefore conclude that the evidence is too limited to
draw a definite conclusion on differences between these
two fluid regimens. Fitzgerald et al.14 also reported sig-
nificantly less hypotension after colloid coload compared
with crystalloid coload. Again, our TSA analysis did not
corroborate this finding. We feel our results are of clinical
relevance because if there were a definite benefit of
colloids, their use would have to be taken more into
consideration despite their potential downsides.
Also, we cannot compare the magnitude of the effect
estimate of the study of Fitzgerald et al.14 and that of our
study because those authors reported odds ratios whereas
we report risk ratios. As the Cochrane Handbook for
Systematic Reviews of Interventions points out, odds
and risk ratio are different when the events of the out-
comes investigated are frequent.80 This is the case for
hypotension, and thus, odds ratios overestimate the effect
of the interventions.
A Cochrane analysis81 from 2017 agrees with the findings
of Fitzgerald et al.,14 in that crystalloid coload is more
effective than preload. Ripolles Melchor et al.82 and the
Cochrane review by Chooi et al.81 compared crystalloids
with colloids regardless of the time-point of administra-
tion and found a significantly reduced risk of hypotension
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when colloids were used. Similar conclusions were drawn
in another meta-analysis from 2013.83
Another advantage of our study is that we included meta-
regressions in the analysis. The dose–response of volume
effect that we established suggests that the more crystal-
loid that is given before spinal anaesthesia, the less
maternal hypotension is seen. This is, however, of little
clinical relevance because crystalloid preloading is the
least effective fluid loading technique. In addition,
1138 Rijs et al.
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sensitivity analyses including only double-blind studies
did not find this relationship. This volume relationship
was not found for either crystalloid or colloid coloading,
perhaps because most of the haemodynamic effects of
sympathetic blockade occur during the first 5 to 7 min
after intrathecal injection and therefore, more volume
would be of little help when given thereafter. From a
practical perspective, this means that when using coload-
ing, a moderate volume (1 l) is likely to be enough, and
there is no benefit to prolonged i.v. fluid administration
thereafter. Excessive fluid may be detrimental after
caesarean section. The lack of a volume relationship
for the colloid preload is more difficult to explain. A
possible explanation could be the more potent volume
expanding effect of colloids, that is reaching a ceiling
volume effect rapidly. However, this would contrast with
a study from Ueyama et al.,72 who found a much lower
incidence of maternal hypotension when preloading with
1 l of colloid instead of only 0.5 l (17% versus 58%,
respectively).
Finally, our findings must be seen in the light of the
growing ambition to include patients undergoing (elec-
tive) caesarean sections in enhanced recovery pro-
grammes with shortened starvation times and proactive
oral fluid consumption prior to surgery. The available
data are not convincing, that this form of oral prehydra-
tion really does prevent spinal anaesthesia-induced hypo-
tension.84,85 On the contrary, prevention of hypotension
has been shown to contribute to enhanced recovery and
therefore must be promoted.86
Limitations
The use of network meta-analysis is a valuable evolution
of standard meta-analysis, although there are some lim-
itations, and interpretation of the results must be under-
taken with care. Transitivity and inconsistency of the
model can have an impact on the results. We tested for
inconsistency between direct and indirect results for all
different comparisons and found no significant difference
(see Figure S1, S2 (supplementary material, http://
links.lww.com/EJA/A403)). Egger’s test implied the pos-
sibility of publication bias. A sensitivity analysis
restricted to double-blind studies only found no indica-
tion for publication bias. Therefore, the corresponding
results may be seen as more robust.
Another limitation is the broad range of definitions of
hypotension among the included studies, which can lead
to different incidences of hypotension.87 However, the
majority of the studies used a decrease in SBP of more
than 20% as the definition.
To analyse the possible confounding effect of vasopres-
sors, we planned to do a subgroup analysis, but only three
of the 49 included studies used a vasopressor prophylac-
tically, although it has been suggested as best current
practice.3,88 Because of low sample size and different
fluid comparisons, we decided that data were too scarce to
perform such an analysis. Because vasopressors were
mostly given therapeutically, we believe that the result
presented must be considered as an effect of the fluids
used. On the contrary, we think this is a major research
gap and only studies that combine fluid with a prophy-
lactic vasopressor allow one to define the added value
of fluid.
Another cause of the heterogeneity may be due to the fact
that we included all amounts of fluids and durations of
administration as defined by the authors, because there is
no minimal volume defined in the literature. Small
volumes of fluid, especially crystalloids, given as a pre-
load or coload are mostly less effective in controlling
hypotension when compared with larger volumes. How-
ever, only two of the included studies reported using
500 ml of crystalloids, all other studies investigated larger
volumes. Also, the exact timing and speed of the infu-
sions play an important role in the treatment effect. For
crystalloids, fluid may not remain in the circulation if the
infusion is slow or is completed sometime before the
spinal. In addition, for an 18-guage cannula a pressure bag
might be required to infuse 500 ml of crystalloid in less
than 7 min. Unfortunately, not all studies reported this
type of important information.
A further limitation is the difficulty of translating the
results of finding the highest protective efficacy with
colloids into clinical practice. Regulatory restrictions have
recently been imposed on hydroxyethylstarch solu-
tions.89 Secondly, only a small amount of data comes
from gelatine solutions and its role in peri-operative care
has also recently been seriously questioned.90
We only included studies on elective caesarean sections,
largely conducted in healthy patients. Our conclusions
therefore cannot be extrapolated to nonelective cases or
women with complex pregnancies or preexisting comor-
bidities. Indeed, it has been reported that in some set-
tings, for example pre-eclamptic patients, spinal-induced
haemodynamic effects are less pronounced and that fluid
loading may not be useful and may even be harmful.91
More recently, Pretorius et al.92 performed a meta-analy-
sis on fluid therapy in pre-eclamptic women and could
not provide a conclusion given the paucity of data.
Finally, there was a heterogeneity in the doses of the local
anaesthetic used across the various studies. Bupivacaine
was mainly used as the local anaesthetic in our included
articles. Low doses of bupivacaine were found to be
associated with less hypotension compared to higher
doses and thus the dose of local anaesthetics may also
play a significant role in the haemodynamic response to
spinal anaesthesia.93
Conclusion
Our meta-analysis supports the efficacy of colloid pre-or
coloading, and of crystalloid coloading to a lesser extent,
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for decreasing the incidence of hypotension during elec-
tive caesarean sections performed under spinal anaesthe-
sia. However, TSA combined with sensitivity analysis
(including only double-blind studies) showed no definite
superiority of any fluid regimen. Due to european
restrictions on the most studied colloid (HES), we rec-
ommend crystalloid coload as the most appropriate fluid
regimen. More research is needed to exactly define the
role of the prophylactic use of vasopressors in relation to
fluid therapy.
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